Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction;Impacto pronóstico de una estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST según la presencia o no de disfunción sistólica

Revista Espanola de Cardiologia

Volumn 63, Issue 8, 2010, Pages 915-924

  Palau, Patricia ^a   Núñez, Julio ^a   Sanchis, Juan ^a   Bodí, Vicent ^a   Rumiz, Eva ^a   Núñez, Eduardo ^a   Miñana, Gema ^a   Merlos, Pilar ^a   Gómez, Cristina ^a   Fácila, Lorenzo ^a   Chorro, Francisco J ^a   Fácila, Ángel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Non ST segment elevation acute coronary syndrome; Prognosis; Revascularization; Systolic dysfunction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; DEATH; FEMALE; HAZARD RATIO; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; ST SEGMENT DEPRESSION; STATISTICAL ANALYSIS; SYSTOLIC DYSFUNCTION; THERAPY EFFECT; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE CORONARY SYNDROME; AGED; FEMALE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; SYSTOLE;

EID: 77957137808     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70203-7     Document Type: Article

References (34)

1. J.P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budaj, and F. Fernández-Avilés Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
2. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction J Am Coll Cardiol 50 2007 1 157
3. R. Qayyum, M.R. Khalid, J. Adomaityte, S.P. Papadakos, and F.C. Messineo Systematic review: Comparing routine and selective invasive strategies for the acute coronary syndrome Ann Intern Med 148 2008 186 196
4. J. Núñez, J. Sanchis, and V. Bodí Estrategia de revascularización invasiva en el síndrome coronario agudo sin elevación del segmento ST. El debate continúa Med Clin (Barc) 18 2009 717 723
5. D.L. Bhatt, M.T. Roe, E.D. Peterson, Y. Li, A.Y. Chen, and R.A. Harrington Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative JAMA 292 2004 2096 2104
6. V. Bodí, J. Sanchis, A. Llácer, L., Núñez J. Fácila, and M. Pellicer Estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST. De los grandes estudios al mundo real Rev Esp Cardiol 57 2004 1143 1150
7. J. Núñez, J., Núñez E. Sanchis, V. Bodí, V. Bertomeu-González, and M.J. Bosch Prognosis differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: experience from two consecutive periods in a single center Eur J Intern Med 18 2007 409 416
8. T. Bauer, O. Koeth, C. Jünger, T. Heer, H. Wienbergen, and A. Gitt Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction Eur Heart J 28 2007 2873 2878
9. J. Sanchis, V. Bertomeu, V. Bodi, J. Núñez, C. Lauwers, and J.M. Ruiz-Nodar Estrategia invasiva en pacientes con diabetes avanzada y síndrome coronario agudo sin elevación del segmento ST. Hallazgos angiográficos y evolución clínica. Resultados del estudio PREDICAR Rev Esp Cardiol 59 2006 321 328
10. M. St John Sutton, M.A. Pfeffer, T. Plappert, J.L. Rouleau, L.A. Moyé, and G.R. Dagenais Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril Circulation 89 1994 68 75 (Pubitemid 24026473)
11. A. Batalla The importance of the left ventricular ejection fraction in the prognosis of early-onset coronary disease Int J Cardiol 75 2000 293 294
12. V. Bodí, J. Sanchis, A. Llácer, L. Fácila, J. Núñez, and M. Pellicer Indicadores pronósticos en el síndrome coronario agudo sin elevación del segmento ST Rev Esp Cardiol 58 2005 198 216
13. E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, and G. Papuchis The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
14. E. Boersma, K.S. Pieper, E.W. Steyerberg, R.G. Wilcox, W.C. Chang, and K.L. Lee Predictors of outcome in patients with acute coronary syndromes without persistent ST segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators Circulation 101 2000 2557 2567
15. K.A. Eagle, M.J. Lim, O.H. Dabbous, K.S. Pieper, R.J. Goldberg, and F. Van de Werf A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733 (Pubitemid 38725422)
16. K.A. Fox, P.A. Poole-Wilson, R.A. Henderson, T.C. Clayton, D.A. Chamberlain, and T.R. Shaw Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina Lancet 360 2002 743 751
17. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, and N. Lakkis Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887 (Pubitemid 32564900)
18. L. Wallentin, B. Lagerqvist, S. Husted, F. Kontny, E. Stahle, and E. Swahn Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease Lancet 356 2000 9 16
19. R.J. De Winter, F. Windhausen, J.H. Cornel, P.H. Dunselman, C.L. Janus, and P.E. Bendermacher Early invasive versus selectively invasive management for acute coronary síndromes N Engl J Med 353 2005 1095 1104
20. P.G. Steg, A. Kerner, F. Van de Werf, J. López-Sendón, J.M. Gore, and G. Fitzgerald Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure Circulation 118 2008 1163 1171
21. L.W. Stevenson, and J.K. Perloff The limited reliability of physical signs for estimating hemodynamics in chronic heart failure JAMA 261 1989 884 888
22. J. Remes, H. Miettinen, A. Reunanen, and K. Pyörälä Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 12 1991 315 321
23. M.E. Bertrand, M.L. Simoons, K.A. Fox, L.C. Wallentin, C.W. Hamm, and E. McFadden Management of acute coronary syndromes in patients presenting without persistent STsegment elevation Eur Heart J 23 2002 1809 1840
24. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513
25. S. Weitzen, K.L. Lapane, A.Y. Toledano, A.L. Hume, and V. Mor Principles for modeling propensity scores in medical research: a systematic literature review Pharmacoepidemiol Drug Saf 13 2004 841 853
26. J.E. Núñez, E. Núñez, L. Fácila, V. Bertomeu, A. Llcer, and V. Bodí Papel del índice de Charlson en el pronóstico a 30 días y 1 año tras un infarto agudo de miocardio Rev Esp Cardiol 57 2004 842 849
27. W.E. Boden, R.A. O'Rourke, M.H. Crawford, A.S. Blaustein, P.C. Deedwania, and R.G. Zoble Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators N Engl J Med 338 1998 1785 1792
28. TIMI IIIB Investigators Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia Circulation 89 1994 1545 1556
29. K. Allman, L.J. Shaw, R. Hachamovitch, and J.E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis J Am Coll Cardiol 39 2002 1151 1158
30. P.G. Camici Hibernation and heart failure Heart 90 2004 141 143
31. S. Plein, J.P. Greenwood, J.P. Ridgway, G. Cranny, S.G. Ball, and M.U. Sivananthan Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging J Am Coll Cardiol 44 2004 2173 2181
32. V. Bodí, J. Sanchis, M.P. López-Lereu, J. Núñez, L. Mainar, and J.V. Monmeneu Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischemic cascade Heart 95 2009 49 55
33. R.W. Nesto, and G.J. Kowalchuk The ischemic cascade: Temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia Am J Cardiol 59 1987 23 30
34. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cuñat, and E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales Rev Esp Cardiol 61 2008 803 816